David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 40,000 shares at $26.17 ($1.0M) on 2025-09-10, disclosed to the SEC on 2025-09-12.
Open-market sale of $1.0M APLS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.17 | 20,000 | $523K | 50.0% |
| 2 | $26.17 | 20,000 | $523K | 50.0% |
| Total | $26.17 avg | 40,000 | $1.0M | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |